Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Safety Lancet Market by Type (Push-Button Safety Lancet, Pressure-Activated Safety Lancet, Side Button Safety Lancet) and by End User (Hospital and Clinic, Diagnostic Center and Pathology Laboratory, Home Diagnostic, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12356

Pages: NA

Charts: NA

Tables: NA

Safety lancet is a single-use, sterile device intended for capillary blood sampling. It is similar to a small scalpel but comes with a double-edged needle or blade. Lancets are often used to make punctures like a fingerstick to obtain blood specimens. They are generally disposable. In addition, safety lancets are used to prick skin in skin testing procedures for detecting allergies. Safety lancets are used by diabetic patients, as they use them to poke a small hole in their fingers for blood. The blood sample is then used to check the blood glucose level. The lancet needle is very thin and tiny, making it prone to bending after a single use, therefore, they are quite safe as they need to be replaced after each cut.

Impact of COVID-19 on the Medical Device Market

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of the infected population. Respiratory support devices such as atomizers, lifesupport machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment, including masks, gloves, and protective eyeglasses. An increase has been witnessed in the need for medical supplies, both from healthcare professionals and the civil population for precautionary measures, owing to the rise in the number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure an adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the safety lancet market.

Top Impacting Factors

The safety lancet market is highly driven by the growth in the prevalence of infectious diseases and different chronic conditions along with rise in the preference toward home healthcare, and improved medical device regulations.

Home care has become one of the most preferred methods of healthcare consulting, due to rise in demand for relaxed and convenient healthcare dispensation. This has attributed to the growth of the safety lancet market.

Moreover, surge in support of the governments in developing economies along with increased healthcare funding on safety lancets has fuelled the growth of the global safety lancet market.

However, lack of awareness still persists in the developing countries when it comes to homecare usage of safety lancets. This can be considered as a major challenge which can act as a hurdle for the global safety lancet market.

Key Market Trends

In the global safety lancet market, the homecare segment is dominating owing to its increase in use among patients who are being diagnosed with chronic diseases such as diabetes as these patients need proper homecare.

Simplicity and ease of using the device have made it an ideal device for self-diagnosing and monitoring diabetes, which can further propel the market growth during the forecast period.

In 2018, HTL-STREFA expanded its storage capacity in Leczyca and was also acquired by Investindustrial. This acquisition helped the company partner for the management of diabetes and serve an extensive customer base.

In 2017, Owen Mumford opened its facility in Malaysia. This was done to accelerate and strengthen the growth of Owen Mumford in the Asia-Pacific.

North America dominates the safety lancet market owing to increase in number of cases of chronic illnesses that require homecare and also due to the region's favorable reimbursement policies. Surge in expenditure of healthcare in this region along with the rise in number of new product launches has further fueled the market growth of safety lancets.

The Asia-Pacific market of safety lancets is projected to grow during the forecast period due to increase in the number of cases of malaria, dengue, chikungunya, all of which require safety lancet devices.

Key Benefits of the Report

  • This study presents the analytical depiction of the safety lancetindustry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the safety lancet market share.
  • The current market is quantitatively analyzed to highlight growth scenario of the safety lancet market.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in the coming years

Questions Answered in the Global Safety Lancet Market Report

  • Which are the leading players active in the safety lancetmarket?
  • How is each segment of the market expected to grow during?
  • What are the adoption trends for safety lancet market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What aresafety lancets?
  • What is the prediction for the safety lancet market in the future?
  • What are the current trends and predicted trends?

Key Market Segments

  • By Type
    • Push-Button Safety Lancet
    • Pressure-Activated Safety Lancet
    • Side Button Safety Lancet
  • By End User
    • Hospital and Clinic
    • Diagnostic Center and Pathology Laboratory
    • Home Diagnostic
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Bayer AG
  • NARANG MEDICAL LIMITED
  • SteriLance Medical
  • Becton and Dickinson Company
  • Terumo Medical Corporation
  • HTL-STREFA S.A.
  • F. Hoffmann-La Roche Ltd.
  • B. Braun Melsungen AG
  • Sterimed Group
  • Amkay Products Pvt. Ltd.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: SAFETY LANCET MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Push-Button Safety Lancet

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Pressure-Activated Safety Lancet

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Side Button Safety Lancet

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: SAFETY LANCET MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospital And Clinic

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diagnostic Center And Pathology Laboratory

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Home Diagnostic

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: SAFETY LANCET MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Safety Lancet Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By End User
      • 6.2.6. Canada Safety Lancet Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By End User
      • 6.2.7. Mexico Safety Lancet Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By End User
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Safety Lancet Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By End User
      • 6.3.6. Germany Safety Lancet Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By End User
      • 6.3.7. Italy Safety Lancet Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By End User
      • 6.3.8. Spain Safety Lancet Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By End User
      • 6.3.9. UK Safety Lancet Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By End User
      • 6.3.10. Russia Safety Lancet Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By End User
      • 6.3.11. Rest Of Europe Safety Lancet Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By End User
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Safety Lancet Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By End User
      • 6.4.6. Japan Safety Lancet Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By End User
      • 6.4.7. India Safety Lancet Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By End User
      • 6.4.8. South Korea Safety Lancet Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By End User
      • 6.4.9. Australia Safety Lancet Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By End User
      • 6.4.10. Thailand Safety Lancet Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By End User
      • 6.4.11. Malaysia Safety Lancet Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By End User
      • 6.4.12. Indonesia Safety Lancet Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By End User
      • 6.4.13. Rest of Asia Pacific Safety Lancet Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By End User
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Safety Lancet Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By End User
      • 6.5.6. South Africa Safety Lancet Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By End User
      • 6.5.7. Saudi Arabia Safety Lancet Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By End User
      • 6.5.8. UAE Safety Lancet Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By End User
      • 6.5.9. Argentina Safety Lancet Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By End User
      • 6.5.10. Rest of LAMEA Safety Lancet Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By End User
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. F. Hoffmann-La Roche Ltd.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Becton And Dickinson Company

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Amkay Products Pvt. Ltd.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Terumo Medical Corporation

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Bayer AG

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. HTL-STREFA S.A.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. B. Braun Melsungen AG

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. SteriLance Medical

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. NARANG MEDICAL LIMITED

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Sterimed Group

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL SAFETY LANCET MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL SAFETY LANCET MARKET FOR PUSH-BUTTON SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL SAFETY LANCET MARKET FOR PRESSURE-ACTIVATED SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL SAFETY LANCET MARKET FOR SIDE BUTTON SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL SAFETY LANCET MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL SAFETY LANCET MARKET FOR HOSPITAL AND CLINIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL SAFETY LANCET MARKET FOR DIAGNOSTIC CENTER AND PATHOLOGY LABORATORY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL SAFETY LANCET MARKET FOR HOME DIAGNOSTIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL SAFETY LANCET MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL SAFETY LANCET MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. U.S. SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 15. U.S. SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. CANADA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. CANADA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. ITALY SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. ITALY SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. UK SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. UK SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. CHINA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. CHINA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. INDIA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 45. INDIA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA SAFETY LANCET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. UAE SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. UAE SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA SAFETY LANCET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA SAFETY LANCET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 74. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 75. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 76. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 77. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. BECTON AND DICKINSON COMPANY: KEY EXECUTIVES
  • TABLE 79. BECTON AND DICKINSON COMPANY: COMPANY SNAPSHOT
  • TABLE 80. BECTON AND DICKINSON COMPANY: OPERATING SEGMENTS
  • TABLE 81. BECTON AND DICKINSON COMPANY: PRODUCT PORTFOLIO
  • TABLE 82. BECTON AND DICKINSON COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. AMKAY PRODUCTS PVT. LTD.: KEY EXECUTIVES
  • TABLE 84. AMKAY PRODUCTS PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 85. AMKAY PRODUCTS PVT. LTD.: OPERATING SEGMENTS
  • TABLE 86. AMKAY PRODUCTS PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 87. AMKAY PRODUCTS PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. TERUMO MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 89. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 90. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 91. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 92. TERUMO MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. BAYER AG: KEY EXECUTIVES
  • TABLE 94. BAYER AG: COMPANY SNAPSHOT
  • TABLE 95. BAYER AG: OPERATING SEGMENTS
  • TABLE 96. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 97. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. HTL-STREFA S.A.: KEY EXECUTIVES
  • TABLE 99. HTL-STREFA S.A.: COMPANY SNAPSHOT
  • TABLE 100. HTL-STREFA S.A.: OPERATING SEGMENTS
  • TABLE 101. HTL-STREFA S.A.: PRODUCT PORTFOLIO
  • TABLE 102. HTL-STREFA S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 104. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 105. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 106. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 107. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. STERILANCE MEDICAL: KEY EXECUTIVES
  • TABLE 109. STERILANCE MEDICAL: COMPANY SNAPSHOT
  • TABLE 110. STERILANCE MEDICAL: OPERATING SEGMENTS
  • TABLE 111. STERILANCE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 112. STERILANCE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. NARANG MEDICAL LIMITED: KEY EXECUTIVES
  • TABLE 114. NARANG MEDICAL LIMITED: COMPANY SNAPSHOT
  • TABLE 115. NARANG MEDICAL LIMITED: OPERATING SEGMENTS
  • TABLE 116. NARANG MEDICAL LIMITED: PRODUCT PORTFOLIO
  • TABLE 117. NARANG MEDICAL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. STERIMED GROUP: KEY EXECUTIVES
  • TABLE 119. STERIMED GROUP: COMPANY SNAPSHOT
  • TABLE 120. STERIMED GROUP: OPERATING SEGMENTS
  • TABLE 121. STERIMED GROUP: PRODUCT PORTFOLIO
  • TABLE 122. STERIMED GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL SAFETY LANCET MARKET SEGMENTATION
  • FIGURE 2. GLOBAL SAFETY LANCET MARKET
  • FIGURE 3. SEGMENTATION SAFETY LANCET MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN SAFETY LANCET MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALSAFETY LANCET MARKET
  • FIGURE 11. SAFETY LANCET MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. SAFETY LANCET MARKET FOR PUSH-BUTTON SAFETY LANCET, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. SAFETY LANCET MARKET FOR PRESSURE-ACTIVATED SAFETY LANCET, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. SAFETY LANCET MARKET FOR SIDE BUTTON SAFETY LANCET, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. SAFETY LANCET MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. SAFETY LANCET MARKET FOR HOSPITAL AND CLINIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. SAFETY LANCET MARKET FOR DIAGNOSTIC CENTER AND PATHOLOGY LABORATORY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. SAFETY LANCET MARKET FOR HOME DIAGNOSTIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. SAFETY LANCET MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: SAFETY LANCET MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. BECTON AND DICKINSON COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. BECTON AND DICKINSON COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. BECTON AND DICKINSON COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. AMKAY PRODUCTS PVT. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. AMKAY PRODUCTS PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. AMKAY PRODUCTS PVT. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. TERUMO MEDICAL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. BAYER AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. BAYER AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. BAYER AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. HTL-STREFA S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. HTL-STREFA S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. HTL-STREFA S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. STERILANCE MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. STERILANCE MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. STERILANCE MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. NARANG MEDICAL LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. NARANG MEDICAL LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. NARANG MEDICAL LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. STERIMED GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. STERIMED GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. STERIMED GROUP: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Safety Lancet Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue